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The 2010 Montagna Symposium, 
Small Molecules: Skin as the First 
Line of Defense,* was attended by 
approximately 100 scientists, clini-
cians, residents, students, industrial 
representatives, and National Institutes 
of Health (NIH) representatives. 
The three-day program comprised 
five sessions: (i) “Science-Driven 
Therapeutics,” (ii) “Host Defense 
Peptides,” (iii) “Neuroendocrine 
Functions in Skin,” (iv) “Small 
Molecules of the Skin Barrier,” and (v) 
“Skin Defense Strategies.”
Two important goals of the meet-
ing were to explore the skin’s innate 
ability to protect itself via small mole-
cules and to determine how scientists 
and clinicians might enhance this 
ability. The sessions were organized 
to reflect these goals, beginning with 
known defensive strategies, moving 
through recent small-molecule dis-
coveries, and, finally, addressing how 
to generate new potential strategies.
In addition to invited speakers, 
several people were selected to 
give short talks based on abstract 
submissions. As in years past, 
discussion after each talk was 
productive and lively.
Michael Zasloff (Georgetown 
University, Washington, DC) opened 
the meeting with a keynote address 
describing wound healing in dol-
phins, which occurs without infec-
tion or an immune infiltrate. Dr. 
Zasloff explained that wounds are 
closed by the blubber layer below, 
which billows upward, resulting in 
an increase in antimicrobials over the 
wound. The dolphins appear to have 
no pain associated with the wounds. 
Dr. Zasloff suggested that this is attrib-
utable to the blubber’s anti-inflamma-
tory and antimicrobial activity.
The goal of the first full session, 
“Science-Driven Therapeutics,” was 
to explore the role of basic science 
in the discovery of novel therapies. 
Barbara Gilchrest (Boston University, 
Massachusetts) began the session 
by describing the discovery of small 
telomeric oligos that could induce 
the tanning response and might there-
fore be a good therapy for prevent-
ing UV-induced skin cancer. She is 
currently working on the problem of 
penetration of the oligos through the 
human skin barrier.
Two talks discussed the skin as 
a neurosensory organ. Peter Elias 
(San Francisco VA Medical Center, 
California) described how psycho-
logical stress induces the produc-
tion of small molecules, such as 
β-defensins, cathelicidin protein, and 
the neuroendocrine peptide cate-
statin, which are necessary during 
the initial inflammatory response of 
wound healing but become deleteri-
ous to barrier function once inflam-
mation resides. Richard Granstein 
(Weill–Cornell Medical Center, 
New York) discussed the skin’s pro-
duction of calcitonin gene–related 
peptide (CGRP), a neuropeptide, and 
its direct anti- and proinflammatory 
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effects on endothelial cells in the 
dermis. Xiao-Jing Wang (University 
of Colorado, Denver) described her 
yin–yang approach to understanding 
the conundrum of how transforming 
growth factor-β1, which suppresses 
the immune system, can induce pso-
riasis, which is caused by an increase 
in the inflammatory response of 
T lymphocytes. William Fenical 
(Scripps Institute of Oceanography, 
University of California, San Diego) 
discussed the lack of immune 
response in ocean-dwelling crea-
tures. He suggested that sea shrimp 
eggs and their bacterial symbiotic 
relationship to produce antibiotic 
peptides against invading bacteria 
might parallel the microbe–tissue 
associations in human skin.
The discussion of inflammation 
and the microbiome of skin was 
continued in the second session, 
“Host Defense Peptides,” by Jens-
Michael Schroeder (University of 
Kiel, Germany) and Michel Gilliet 
(University of Texas M.D. Anderson 
Cancer Center, Houston). Dr. 
Schroeder explained that skin has 
a high level of natural bacteria, but 
that invading bacteria induce the skin 
to produce high levels of antimicro-
bial peptides. Dr. Gilliet followed 
with evidence that the induced anti-
microbial peptides trigger activa-
tion of plasmacytoid dendritic cells 
and that miscontrol of this process 
might lead to psoriasis. Jamie Bernard 
(University of California, San Diego), 
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a Farber Travel Award Winner, 
explained that Cox-2 is required to 
enhance the antimicrobial peptide 
expression in keratinocytes. Andrew 
Johnston (University of Michigan, 
Ann Arbor) reported that IL-1 family 
members, which induce antimicro-
bial peptides in skin, are inhibited by 
psoriatic treatments.
The third scientific session, 
“Neuroendocrine Functions in Skin,” 
explored the relationship between 
neuroendocrine function and anti-
microbial activity of the skin. Martin 
Steinhoff (University of California, 
San Francisco) began the session with 
an overview of the skin as a neuro-
immune organ. He explained that 
the skin is the first line of immune 
and sensory detection, sending dan-
ger signals to the brain. Katherine 
Raek (Loyola University, Chicago, 
Illinois) described a study in which 
stress activated the nicotinic recep-
tors in skin keratinocytes, resulting 
in a reduction of cutaneous antimi-
crobial activity. Stephen Ostrowski 
(Case Western Reserve University, 
Cleveland, Ohio), a Farber Travel 
Award winner, explained that nerve-
derived substance P and CGRP help 
sustain cutaneous cell infiltration 
and contribute to acanthosis. Daniel 
Bikle (University of California, San 
Francisco) gave a general overview 
of the nonclassic functions of vita-
min D and the vitamin D receptor. 
He emphasized that cell types that 
make their own vitamin D appear 
to be able to ward off infection. This 
was followed by short talks from two 
Farber Travel Award Winners. Jose 
Fernandez (Signum Biosciences, 
Monmouth, New Jersey) discussed 
safety issues involved with topical 
antimicrobial treatments, and Ferda 
Cevikbas (University of California, 
San Francisco) described how IL-31 
results in increased scratching and 
CGRP release.
In the fourth session, “Small 
Molecules of the Skin Barrier,” 
Thomas Luger (University of Münster, 
Germany) further explored the role of 
neuropeptides in mediating inflam-
mation and the innate defense of the 
skin as a barrier. Robert Hancock 
(University of British Columbia, 
Vancouver, Canada) outlined his tech-
nique for rapidly building and test-
ing small molecules and their ability 
to boost the skin’s innate immunity. 
Luowei Li (National Cancer Institute 
(NCI), NIH, Bethesda, Maryland) dis-
cussed the necessity of a function-
ing ABCB1 multidrug transporter to 
deliver chemotherapeutic agents. Two 
talks concerning the skin’s micro-
biome were presented. Heidi Kong 
(NCI, NIH) described the variability 
of the bacterial complement across 
skin from several body sites. She 
explained that the healthy state is 
associated with much diversity and 
emphasized that general destruction 
of the innate microbiome is associ-
ated with disease. Richard Gallo 
(University of California, San Diego) 
continued this theme, explaining how 
the host microbiome contributes to 
the host defense through production 
of antimicrobial peptides that fight 
invading microbes. Stephanie Shirley 
(University of Texas M.D. Anderson 
Cancer Center) discussed the role of 
the transcription factor Slug in pro-
ducing dimmers of S100 proteins, 
which are antimicrobial.
In the last scientific session, “Skin 
Defense Strategies,” Richard Eckert 
(University of Maryland School of 
Medicine, Baltimore) presented an 
overview of S100 proteins in the epi-
dermis. He emphasized that specific 
S100 proteins bound in the cornified 
cell envelope are released upon bac-
terial invasion and that these S100 
proteins can kill Escherichia coli but 
do not kill Staphylococcus aureus. 
Adrian Gombert (Linus Pauling 
Institute, Oregon State University, 
Corvallis) described his mouse 
model, which contains a primate-
specific, vitamin D–regulated cathe-
licidin antimicrobial peptide. Ronald 
Wolf, a Farber Travel Award win-
ner (Ludwig Maximilian University, 
Munich, Germany), ended the session 
with a discussion of a mouse model 
that in basal keratinocytes overex-
presses the S100A7 and S100A15 
genes, two peptides highly expressed 
in psoriasis. The meeting ended with 
an overall discussion session entitled 
“Translation to Treatment: What’s the 
Next Step?”
2010 SiD eugene m. Farber travel 
Awards For Young investigators
As in the past, nine young inves-
tigators attended the Montagna 
Symposium thanks to a gener-
ous donation from the Eugene M. 
Farber family through the Society for 
Investigative Dermatology:
Jamie Bernard, phD 
Postdoctoral fellow, Division of 
Dermatology, University of California, 
San Diego, CA
Ferda Cevikbas, phD
Postdoctoral fellow, Department of 
Dermatology, University of California, 
San Francisco, CA
melanie Dispenza, BS
MD/PhD candidate, Department 
of Cellular/Molecular Physiology, 
Pennsylvania State University College 
of Medicine, Hershey, PA
Jose Fernandez, phD
Senior Research Scientist, Signum 
Biosciences, Inc., Monmouth, NJ
Akihiko ikoma, mD, phD
Postdoctoral fellow, Department of 
Dermatology, University of California, 
San Francisco, CA
Heather mcgee, mS
MD/PhD candidate, Department of 
Immunology, Yale University School of 
Medicine, New Haven, CT
Stephen ostrowski, mD, phD
Resident, Department of Dermatology, 
Case Western Reserve University, 
Cleveland, OH
So Yeon paek, BS
MD candidate, University of Texas 
Southwestern Medical School, Dallas, 
TX (former fellow at the Dermatology 
Branch, NCI, NIH, Bethesda, MD)
ronald Wolf, mD
Postdoctoral fellow, Laboratory of 




MD/PhD candidate, Pennsylvania 
State University College of Medicine, 
Hershey, PA
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*The 2010 Montagna Symposium, “Small Mol-
ecules: Skin as the First Line of Defense,” was held 
at the Salishan Resort in Gleneden Beach, Oregon, 
USA, 7–11 October 2010. Information about 
content and support of past symposia and the next 
Montagna Symposium on the Biology of Skin can 
be found at http://www.montagnasymposium.org.
montagna 2011: 60th Anniversary
“pioneering Skin research: Catalyzing Advances in Science and medicine”
13–17 october 2011, Skamania Lodge,  
Columbia river gorge national Scenic Area, Stevenson, Washington
Program Chair: Stuart Yuspa, MD
National Cancer Institute, 
National Institutes of Health, Bethesda, Maryland
